Atossa Genetics Inc.

Atossa Genetics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$6.7
Market Cap
$20.88 M
Shares Outstanding
9.12 M
Public Float
5.43 M

Profile

Address
107 Spring Street
Seattle Washington 98104
United States
Employees -
Website http://www.atossagenetics.com
Updated 07/08/2019
Atossa Genetics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65.

Financials

View All

Steven C. Quay
Chairman, President & Chief Executive Officer
Shu Chih Chen
Director